Henrik Jungaberle
Has grant
Chief Executive Officer
GermanyResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Henrik Jungaberle is the Chief Executive Officer at OVID Health Systems, Germany. His research interests focus on psychedelic therapy, particularly its implementation and psychotherapeutic processes. Recent publications address the efficacy and safety of psychedelics in mental health care and the challenges faced in psychedelic drug trials.
Recent Grants
Grant: Close
REBOUND 1.0 - Implementation Research and Adaption
Open Date: 2013-03-01
Close Date: 2014-03-01
Grant: Close
REBOUND - Resilience-based drug education
Open Date: 2010-01-01
Close Date: 2012-12-01
Grant: Close
REBOUND - Resilience-based Drug Education
Open Date: 2010-01-01
Close Date: 2012-12-01
Grant: Close
Ritual Dynamics and Salutogenesis in the Use and Abuse of Psychoactive Substances (RISA Part I1I)
Open Date: 2009-07-01
Close Date: 2013-06-01
Grant: Close
Ritual Dynamics and Salutogenesis in the Use and Abuse of Psychoactive Substances (RISA Part 1I)
Open Date: 2005-07-01
Close Date: 2009-06-01
Articles (10)
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2022
Year:
2022
Year:
2021
Year:
2020
Year:
2020
Year:
2020
Collaborators (3)
Michael Koslowski
Charité - Universitätsmedizin Berlin
Toby Lea
Adjunct Senior Lecturer
UNSW Sydney
Gerhard Gründer
Heidelberg University
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.